This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of Utah Research Foundation. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2022
Title: Te-Wei Chu: Innovator in Apoptosis Research
Introduction
Te-Wei Chu is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of apoptosis research, holding 2 patents that focus on innovative compositions and methods for inducing apoptosis. His work is essential in advancing our understanding of cell death mechanisms, which has implications in various medical fields.
Latest Patents
Te-Wei Chu's latest patents include compositions and methods for inducing apoptosis. In one aspect, the invention relates to compositions, methods, and kits designed for inducing apoptosis. This abstract serves as a scanning tool for purposes of searching in the particular art and is not intended to limit the present invention. The focus on apoptosis is crucial for developing therapeutic strategies in cancer treatment and other diseases.
Career Highlights
Te-Wei Chu is affiliated with the University of Utah Research Foundation, where he continues to explore innovative solutions in his field. His research has garnered attention for its potential applications in medicine and biology.
Collaborations
Some of his notable coworkers include Jindrich Henry Kopecek and Jiyuan Yang, who contribute to the collaborative efforts in research and development within the institution.
Conclusion
Te-Wei Chu's work in apoptosis research exemplifies the importance of innovation in the scientific community. His contributions through patents and collaborations continue to pave the way for advancements in medical research and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
